Evaluation of Inflammation of the Anterior Segment by Laser Flashmeter in Patients Having Undergone Surgery of the Posterior Segment (Vitrectomy or Preindentation) During the First Postoperative Year. (FLAVIC)
NCT ID: NCT03677700
Last Updated: 2018-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2018-09-30
2020-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy
NCT01969929
Vitreous Detachment and Glaucoma Progression
NCT04719871
The Role of Intravitreal Glucose in Macular Thinning Following Surgery for Retinal Detachment or Epimacular Membrane
NCT02210481
Evaluation of Multifocal ERG and Visual Field Changes After Vitrectomy and ILM Peeling
NCT04281173
Choroidal Thickness Vitrectomy
NCT02617147
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this study, the investigators wish to study postoperative inflammation in patients operated for posterior segment ocular surgery (vitrectomy or preindentation) measured by laser flashmeter on a follow-up of one year.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laser Flare Meter
Measurement of the inflammation of the operated eye and the fellow eye before the surgery and at each post-surgery visit: D7, M1, M2, M3, M6, M12
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Operation of vitrectomy or preindentation in the ophthalmology department of Rennes University Hospital for one of the following reasons:
* Retinal detachment, rhegmatogenous or not
* Combined surgery
* Membrane peeling
* Macular hole
* Optically targeted vitrectomy (Terson's syndrome, intravitreous haemorrhage)
* Covered by a health insurance system,
* Having received information on the protocol and not having expressed opposition to participating in the study
Exclusion Criteria
* Patient with vitreoretinal proliferation (grade B and C),
* Pregnant or nursing woman,
* Major patient subject to legal protection (safeguard of justice, guardianship, guardianship), person deprived of liberty.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rennes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dalal ASRI
Role: PRINCIPAL_INVESTIGATOR
Rennes University Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
35RC18_3043_FLAVIC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.